1
Return

Impaired Lung BCAA Metabolism Promotes Ferroptosis and Resultant Pulmonary Arterial Hypertension-Associated Hepatopathy

delete2026-05-30
delete0
delete
OA
AI
M
Madelyn J. Blake
J
Jason Hong
A
Adam J. Brownstein
C
Christopher J. Rhodes
E
Emilia M. Swietlik
J
Jeffrey C. Blake
R
Ryan A. Moon
L
Lynn M. Hartweck
J
Jenna B. Mendelson
S
Sasha Z. Prisco
T
Todd Markowski
L
LeeAnn Higgins
K
Kevin Murray
C
Candance Guerrero
S
Sandra Breuils-Bonnet
S
Steeve Provencher
J
Joanna Pepke-Zaba
M
Mark Toshner
M
Martin Wilkins
S
Sebastien Bonnet
DOI:10.1016/j.jacbts.2026.101573delete
deleteOriginal
deleteShare
deleteSave
View PDF
Abstract

Abstract

En 中文
• Dysregulated lung BCAA metabolism contributes to PAH and multiorgan dysfunction. • Impaired BCAA catabolism promotes PASMC ferroptosis and pulmonary vascular remodeling. • Enhancing BCAA catabolism improves PAH severity, right ventricular function, and counteracts hepatic abnormalities. • Future studies could evaluate BCAA-targeted therapies as novel metabolic therapies in PAH patients.
Keywords:
branched-chain amino acids
ferroptosis
hepatopathy
pulmonary arterial hypertension
right ventricular failure
BCAA
branched-chain amino acid
MCT
monocrotaline
PAH
pulmonary arterial hypertension
PASMC
pulmonary artery smooth muscle cell
RVSP
right ventricular systolic pressure
SMC
smooth muscle cell
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

J
jacc: basic to translational science
IF:
0
Papers:
81
Citations:
0

Organization

No organization information available
Cited Papers

Cited Papers

Citing Papers

Citing Papers